Dan Hazen

Dan Hazen is the Controller at Priovant Therapeutics. He has over 13 years of financial and accounting experience, most recently as the Controller at Esperion Therapeutics. He joined Esperion during its early biotech stage and helped create and implement many of the financial, accounting, and operational processes that supported its transition from R&D to commercialization. Prior to Esperion, Dan worked at PwC in its assurance practice, where he earned his CPA. Dan holds a BBA and MBA from the University of Michigan.